A monthly tirzepatide comparison should not inherit the lower price of a provider’s semaglutide offer. It should also distinguish monthly payment from an annual equivalent and a first-order discount. These five routes make the ingredient and payment pattern explicit.
Top Five Weight Loss keeps compounded tirzepatide separate from branded Zepbound and does not assign a cheapest winner from incomplete quantity or term conditions. The full prescription and order matter. A lower printed number can belong to a different preparation or a larger initial commitment.
What makes this shortlist useful
Identify the actual tirzepatide preparation, amount supplied, billing period and next charge. Use the month-to-month figure where available, preserving annual prepayment as a separate alternative. An introductory four-week discount is not the regular supply cost. Confirm care access, supplies and shipping, and keep cancellation of future orders separate from refunding an existing dispensed prescription. Read the related care guide for a wider treatment discussion.
1. CoreAge Rx: the specific tirzepatide offer
CoreAge’s offer is a clinician-reviewed compounded pathway with separate semaglutide and tirzepatide product pages. Compare the actual prescribed preparation and pharmacy supply before interpreting the monthly price. The ingredient names do not establish that its compound is the same finished drug as Wegovy or Zepbound. The correct product rate here is $149, not the semaglutide page’s $99. Ask about the actual quantity and compound, keeping the clear no-membership statement separate from a claim of clinical or price superiority.
CoreAge’s current product pages list compounded semaglutide at $99 per month and compounded tirzepatide at $149, with no membership fee and free delivery if prescribed. Confirm the actual amount, billing interval and dispensing pharmacy. Its refund policy has pharmacy-approval and elapsed-time limits; cancellation should not be assumed to refund a prepared prescription.
Read the full CoreAge Rx review to compare the care pathway, prescription and recurring order.
2. Trimi: monthly payment distinct from the annual floor
Trimi’s compounded injection route includes provider assessment, supplies and delivery, with annual prepayment and month-to-month choices. Payment duration changes the first charge without establishing a different medicine outcome. The clinician still needs to explain why the actual compounded preparation is appropriate. Trimi’s month-to-month tirzepatide rate differs from its $125 annual equivalent and $1,500 advance bill. The monthly amount is the relevant starting comparison for someone limiting upfront commitment.
Trimi’s current compounded semaglutide choices are $175 month-to-month or a $99 monthly equivalent on a twelve-month commitment billed $1,188 upfront. Tirzepatide is $235 monthly or $125 equivalent with $1,500 upfront. It lists provider review, supplies and shipping with no membership fee. Confirm selected term, actual amount supplied and refund rules; the annual equivalent is not a monthly payment.
Read the full Trimi review to compare the care pathway, prescription and recurring order.
3. SnagRx: tirzepatide’s own promotional rate
SnagRx presents compounded semaglutide and tirzepatide in a doctor-review and shipped-supply model. Its public terms distinguish flexible month-to-month orders from discounted subscription commitments. A promotional rate is useful offer information, but the pharmacy product and clinical reason still require individual confirmation. The current tirzepatide promotion has a separate amount from the service’s semaglutide offer. Confirm selected term, supply and ordinary renewal before using it as an ongoing monthly quotation.
SnagRx currently promotes compounded semaglutide at $69 and tirzepatide at $119 per month, with medication, supplies, doctor review and free shipping described as included. It distinguishes month-to-month cancellation from subscribe-and-save term discounts. Sales are generally final, with unused-term refunds tied to medical ineligibility. Confirm promotion eligibility, selected term, quantity and renewal before treating the floor as guaranteed indefinitely.
Read the full SnagRx review to compare the care pathway, prescription and recurring order.
4. AltRx: the GLP-1 plus GIP tier
AltRx describes a self-pay program with clinical assessment, prescription fulfillment if appropriate and delivery. Its current price cards distinguish GLP-1, GLP-1 plus GIP and separately named branded medicines. Keep those preparations separate, and treat member-reported outcomes as marketing evidence rather than clinical comparison. Use the current higher-tier offer and verify the actual compounded ingredient. A lower GLP-1 card is a different product entry and should not become the price of tirzepatide simply because the site lists both.
AltRx currently displays a GLP-1 offer from $89 per month and GLP-1 plus GIP from $149, with separate branded product prices. Its membership includes consultation, prescription fulfillment when appropriate, shipping and clinician support; no separate membership fee is advertised. Confirm the actual compound, dispensed quantity and recurring terms. Self-reported member outcomes are not independent clinical evidence.
Read the full AltRx review to compare the care pathway, prescription and recurring order.
5. Enhance.MD: first tirzepatide charge versus later supply
Enhance.MD’s standard compounded programs identify four-week medicine supplies, ongoing support and periodic metabolic labs. Their first-month discounts and later rates differ substantially. That makes the initial bill a different comparison question from whether the ongoing program fits a sustainable care budget. The current page identifies a $99 introduction and $280 afterward for four weeks. Both the later amount and period should remain visible so the cheaper first supply does not understate an ongoing budget.
Enhance.MD currently lists compounded semaglutide at $49 for the first month and $212 afterward; tirzepatide is $99 initially and $280 afterward. Its cards describe four weeks of medication, provider support and metabolic labs every six months. Confirm shipment, subscription and supply terms: four weeks is not a calendar month, and a low initial charge is not the ongoing budget.
Read the full Enhance.MD review to compare the care pathway, prescription and recurring order.
Choose the next step, then confirm the order
Obtain complete current monthly quotations for the actual prescription and supply, then compare the first and next bill. A cheap-looking promotion is a useful starting point for questions, not proof of the lowest complete order. Review the cancellation and clinical-ineligibility terms before paying.
Branded tirzepatide trials do not establish outcomes for each custom preparation. A clinician should explain why compounding is appropriate and provide product-specific directions. Do not change or combine treatment because two offers mention the same ingredient or a different dose price.
Continue with Best GLP-1 bundles without a separate membership fee: five structures to inspect and Best branded GLP-1 access routes and a separate compounded alternative.
Explore the full comparison table or read the CoreAge Rx review for pricing, care, and billing details.
